Total Current Liabilities

$46.74M

Quarterly · Period ending: Jun 30, 2026 · USD

LGND Total Current Liabilities

Latest reported$46.74Mperiod endingJun 30, 2026

LGND Quarterly Current Liabilities ($5.10M → $46.74M)

Quarterly total current liabilities

High-resolution chart · PNG

LGND total current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Total Current Liabilities — Quarterly (USD)
Period ending	Total Current Liabilities (USD)
Jun 30, 2026	46,736,000
Mar 31, 2026	40,667,000
Dec 31, 2025	37,447,000
Sep 30, 2025	30,539,000
Jun 30, 2025	64,734,000
Mar 31, 2025	58,683,000
Dec 31, 2024	37,112,000
Sep 30, 2024	24,772,000
Jun 30, 2024	18,565,000
Mar 31, 2024	17,818,000
Dec 31, 2023	16,782,000
Sep 30, 2023	15,727,000
Jun 30, 2023	29,388,000
Mar 31, 2023	98,929,000
Dec 31, 2022	98,810,000
Sep 30, 2022	135,241,000
Jun 30, 2022	167,853,000
Mar 31, 2022	42,578,000
Dec 31, 2021	41,665,000
Sep 30, 2021	36,297,000
Jun 30, 2021	52,497,000
Mar 31, 2021	95,805,000
Dec 31, 2020	100,111,000
Sep 30, 2020	42,300,000
Jun 30, 2020	29,264,000
Mar 31, 2020	20,438,000
Dec 31, 2019	17,002,000
Sep 30, 2019	35,695,000
Jun 30, 2019	108,985,000
Mar 31, 2019	186,777,000
Dec 31, 2018	82,249,000
Sep 30, 2018	793,344,000
Jun 30, 2018	632,850,000
Mar 31, 2018	246,979,000
Dec 31, 2017	238,868,000
Sep 30, 2017	231,683,000
Jun 30, 2017	225,840,000
Mar 31, 2017	226,995,000
Dec 31, 2016	227,129,000
Sep 30, 2016	226,131,000
Jun 30, 2016	220,347,000
Mar 31, 2016	12,240,000
Dec 31, 2015	20,836,000
Sep 30, 2015	16,253,000
Jun 30, 2015	17,949,000
Mar 31, 2015	18,157,000
Dec 31, 2014	22,779,000
Sep 30, 2014	18,433,000
Jun 30, 2014	18,621,000
Mar 31, 2014	21,005,000
Dec 31, 2013	28,939,000
Sep 30, 2013	32,461,000
Jun 30, 2013	32,571,000
Mar 31, 2013	33,017,000
Dec 31, 2012	35,439,000
Sep 30, 2012	29,879,000
Jun 30, 2012	30,419,000
Mar 31, 2012	27,206,000
Dec 31, 2011	43,643,000
Sep 30, 2011	42,454,000
Jun 30, 2011	42,315,000
Mar 31, 2011	44,570,000
Dec 31, 2010	33,488,000
Sep 30, 2010	36,680,000
Jun 30, 2010	43,598,000
Mar 31, 2010	41,434,000
Dec 31, 2009	52,172,000
Sep 30, 2009	53,047,000
Jun 30, 2009	48,202,000
Mar 31, 2009	52,884,000
Dec 31, 2008	70,614,000
Sep 30, 2008	51,701,000
Jun 30, 2008	44,612,000
Mar 31, 2008	44,311,000
Dec 31, 2007	50,968,000
Sep 30, 2007	59,832,000
Jun 30, 2007	68,058,000
Mar 31, 2007	340,501,000
Dec 31, 2006	170,810,000
Sep 30, 2006	226,415,000
Jun 30, 2006	268,412,000
Mar 31, 2006	256,029,000
Dec 31, 2005	235,211,000
Sep 30, 2005	224,595,000
Jun 30, 2005	213,481,000
Mar 31, 2005	216,216,000
Dec 31, 2004	216,712,000
Sep 30, 2004	71,529,000
Jun 30, 2004	61,470,000
Mar 31, 2004	57,258,000
Dec 31, 2003	54,049,000
Sep 30, 2003	46,290,000
Jun 30, 2003	35,154,000
Mar 31, 2003	37,823,000
Dec 31, 2002	30,535,000
Sep 30, 2002	27,610,000
Jun 30, 2002	31,681,000
Mar 31, 2002	78,315,000
Dec 31, 2001	31,726,000
Sep 30, 2001	25,032,000